缺血性心脏病；_心脑通络液；_基因____

心脑通络液治疗缺血性心脏病机理的实验研究

http://www.100md.com 《时珍国医国药》 2006年第9期

缺血性心脏病；,心脑通络液；,基因,,缺血性心脏病；,心脑通络液；,基因,1材料与方法,2结果,3讨论,参考文献：

     摘要：目的探讨心脑通络液治疗缺血性心脏病的机理。方法使用兔开胸结扎冠状动脉造成缺血性心脏病模型，将30只兔随机分成5组，即假手术组、模型组、地奥心血康组、心脑通络液高、低剂量组。2 d后检测NO及其基因表达，ET1及其基因表达。结果心脑通络液能升高NO水平，降低ET1水平，升高ecNOS mRNA水平，降低ET1 mRNA水平，疗效优于地奥心血康组(P<0.05 ) 。结论心脑通络液能从基因转录和翻译水平对ecNOS， ET1进行调节，显著升高家兔心肌缺血后血清中NO水平，降低ET1水平，减轻缺血状态下对心肌细胞和血管内皮细胞造成的损害，具有保护缺血心肌细胞及血管内皮功能的功效。

    关键词：缺血性心脏病；心脑通络液；基因

    Experimental Study on Mechanism of Treating Ischemia Heart Disease with Xinnaotongluoye

    LI Yan, LU Ruihua, WU Xian

    (The First Hospital Attached to Heilongjiang University of Traditional Chinese Medicine, 150040, China)

    Abstract：ObjectiveTo study mechanism of treating Ischemia heart disease with Xinnaotongluoye. MethodsMade the model of AMI by tieing up the rabbit`s coronary artery. Divided the rabbits into five groups. After two days the NO,Et1 and their mRNA level were observed.ResultsThe study showed Xinnaotongluoye could make level of NO and its mRNA up and the level of ET1 and its mRNA down, the relative effect was more significant in the Xinnaotongluoye group than the Diaoxinxuekang group (P<0.05). ConclusionXinnaotongluoye can improve the level of NO and its mRNA, the level of ET1 and its mRNA to protect the myocardium against the harm of Ischemia heart disease. ......

百拇医药网 http://www.100md.com/html/DirDu/2007/02/17/37/50/91.htm

您现在查看是摘要页，全文长 11323 字符。